Nobilis Therapeutics published the results of its pioneering clinical trial on 81 patients with Panic Disorder in the Journal of Translational Medicine. Patients were treated with NBTX-001 with remarkable results. This study validates the company’s methodology and paves the way to the upcoming studies in PTSD and Alzheimer’s Dementia. Please click here to read the original article and here to read the press release.
